Darren Pan

Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma

Tarek H. Mouhieddine, Oliver Van Oekelen, David T. Melnekoff et al. · Blood Advances · 2022 · 40 citations · Full text

Medicine, Immunology, Oncology +17

Increased Incidence of Nocardial Infections in an Era of Atovaquone Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Alfonso Molina, Drew J. Winston, Darren Pan et al. · Biology of Blood and Marrow Transplantation · 2018 · 38 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma

Mateo Mejía Saldarriaga, Darren Pan, Caitlin Unkenholz et al. · Blood Advances · 2024 · 33 citations · Full text

Medicine, Hematology, Immunology +15

Sequential targeting in multiple myeloma: talquetamab, a GPRC5D bispecific antibody, as a bridge to BCMA CAR-T therapy

Binod Dhakal, Othman Salim Akhtar, David Fandrei et al. · Blood · 2025 · 24 citations

Life Sciences, Oncology, Pharmacology +17

Outcomes with panobinostat in heavily pretreated multiple myeloma patients

Darren Pan, Tarek H. Mouhieddine, Ranjan Upadhyay et al. · Seminars in Oncology · 2023 · 23 citations

Medicine, Hematology, Oncology +12